Latest period
1.56B
YoY change
-0.1%
5Y CAGR
+3.5%
Peak year (1999)
1.78B
Latest annual
1.56B
Shares Outstanding history chart for AstraZeneca (AZN) from 1990 to 2025
Latest: 1.56B
Shares Outstanding growth chart for AstraZeneca (AZN) from 1990 to 2025
Latest: -0.1%
Shares Outstanding history table for AstraZeneca (AZN) from 1990 to 2025
| 2025 | 1.56B | -0.1% | -1.00M | ||
| 2024 | 1.56B | +0.1% | +1.00M | ||
| 2023 | 1.56B | +0.1% | +2.00M | ||
| 2022 | 1.56B | +9.3% | +133.00M | ||
| 2021 | 1.43B | +8.7% | +114.00M | ||
| 2020 | 1.31B | +0.9% | +12.00M | ||
| 2019 | 1.30B | +2.7% | +34.00M | ||
| 2018 | 1.27B | 0.0% | 0 | ||
| 2017 | 1.27B | +0.1% | +1.00M | ||
| 2016 | 1.27B | +0.1% | +1.00M | ||
| 2015 | 1.26B | +0.1% | +1.00M | ||
| 2014 | 1.26B | +0.8% | +10.00M | ||
| 2013 | 1.25B | -0.8% | -10.00M | ||
| 2012 | 1.26B | -7.5% | -103.00M | ||
| 2011 | 1.37B | -5.5% | -79.00M | ||
| 2010 | 1.45B | -0.3% | -4.00M | ||
| 2009 | 1.45B | -0.2% | -3.00M | ||
| 2008 | 1.45B | -3.0% | -45.00M | ||
| 2007 | 1.50B | -4.6% | -72.00M | ||
| 2006 | 1.57B | -3.0% | -48.00M | ||
| 2005 | 1.62B | -3.3% | -55.00M | ||
| 2004 | 1.67B | -2.1% | -36.00M | ||
| 2003 | 1.71B | -1.5% | -26.00M | ||
| 2002 | 1.74B | -1.3% | -23.00M | ||
| 2001 | 1.76B | -0.6% | -10.00M | ||
| 2000 | 1.77B | -0.5% | -8.00M | ||
| 1999 | 1.78B | +90.2% | +842.40M | ||
| 1998 | 933.60M | -1.8% | -17.40M | ||
| 1997 | 951.00M | +0.4% | +4.00M | ||
| 1996 | 947.00M | +0.1% | +1.00M | ||
| 1995 | 946.00M | 0.0% | 0 | ||
| 1994 | 946.00M | +11.3% | +96.00M | ||
| 1993 | 850.00M | +18.6% | +133.41M | ||
| 1992 | 716.59M | 0.0% | 0 | ||
| 1991 | 716.59M | 0.0% | 0 | ||
| 1990 | 716.59M | — | — |
- 20251.56B-0.1%
- 20241.56B+0.1%
- 20231.56B+0.1%
- 20221.56B+9.3%
- 20211.43B+8.7%
- 20201.31B+0.9%
- 20191.30B+2.7%
- 20181.27B0.0%
- 20171.27B+0.1%
- 20161.27B+0.1%
- 20151.26B+0.1%
- 20141.26B+0.8%
- 20131.25B-0.8%
- 20121.26B-7.5%
- 20111.37B-5.5%
- 20101.45B-0.3%
- 20091.45B-0.2%
- 20081.45B-3.0%
- 20071.50B-4.6%
- 20061.57B-3.0%
- 20051.62B-3.3%
- 20041.67B-2.1%
- 20031.71B-1.5%
- 20021.74B-1.3%
- 20011.76B-0.6%
- 20001.77B-0.5%
- 19991.78B+90.2%
- 1998933.60M-1.8%
- 1997951.00M+0.4%
- 1996947.00M+0.1%
- 1995946.00M0.0%
- 1994946.00M+11.3%
- 1993850.00M+18.6%
- 1992716.59M0.0%
- 1991716.59M0.0%
- 1990716.59M—
Shares Outstanding values are taken from AstraZeneca's reported income statements (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's latest reported diluted shares outstanding is 1.56B. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of AstraZeneca (AZN) diluted shares outstanding is 1.56B – edged down 0.1% year-over-year.
Over 2020–2025 (5 years), AstraZeneca diluted shares outstanding expanded at a +3.5% compound annual rate, with mixed annual results across the window.
AstraZeneca diluted shares outstanding declined from 1.78B in 1999 to 1.56B in 2025, a 12.0% drawdown.
1999 marks the peak diluted shares outstanding at 1.78B, with the historical low of 716.59M recorded in 1990.
AstraZeneca Shares Outstanding by Year
AstraZeneca Shares Outstanding 2025: 1.56B
2025's diluted shares outstanding for AstraZeneca came in at 1.56B, edged down 0.1% below 2024.
AstraZeneca Shares Outstanding 2024: 1.56B
AstraZeneca posted diluted shares outstanding of 1.56B in 2024, edged up 0.1% from 2023.
AstraZeneca Shares Outstanding 2023: 1.56B
In 2023, AstraZeneca reported diluted shares outstanding of 1.56B, edged up 0.1% from 2022.
AstraZeneca Shares Outstanding 2022: 1.56B
AstraZeneca diluted shares outstanding in 2022 was 1.56B, grew 9.3% from 2021.
AstraZeneca Shares Outstanding 2021: 1.43B
AstraZeneca diluted shares outstanding in 2021 was 1.43B.
See more financial history for AstraZeneca (AZN).
Sector peers by Shares Outstanding
Healthcare peers of AstraZeneca (AZN), ranked by their latest diluted shares outstanding
| 4.45B | |
| 2.51B | |
| 2.43B | |
| 1.77B | |
| 910.00M | |
| 898.00M | |
| 542.00M | |
| 377.00M |
- 4.45B
- 2.51B
- 1.77B
- 910.00M
- 898.00M
- 542.00M
Frequently asked questions
AstraZeneca (AZN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation